本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.05
-1.0300-8.53%
成交量:26.34萬
成交額:296.77萬
市值:3.85億
市盈率:-9.98
高:12.37
開:12.11
低:10.96
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,488.27萬
流通股本:1,845.34萬
量比:2.85
換手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):-1.1074
每股收益(LYR):-0.9800
淨資產收益率:-33.21%
總資產收益率:-22.67%
市淨率:2.18
市盈率(LYR):-11.28

資料載入中...

2021/04/29

重要事件披露

8-K - Current report
2021/04/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/28

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/27

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/24

重要事件披露

8-K - Current report
2021/02/18

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/19

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/15

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/03

重要事件披露

8-K - Current report